4:00—5:30 PM
Center for Global Development
2055 L St NW
- Fifth Floor
Washington, DC 20036

Tackling Antimicrobial Resistance in Developing Countries: The Role of Aid and International Agencies



Lord Jim O’Neill of Gatley
Chairman, Antimicrobial Resistance Review

Lawrence Kerr
Director, Pandemics and Emerging Threats, Office of Global Affairs, Health and Human Services

Amanda Glassman
Vice President for Programs and Director of Global Health Policy, Center for Global Development

Antimicrobial resistance (AMR) threatens future growth and prosperity, as well as health. Without global action, the UK's Review on Antimicrobial Resistance, led by Lord Jim O'Neill, estimates that an additional 10 million people will die every year from drug-resistant infections and the global economy will experience a loss of $100 trillion by 2050. The impact from rising drug resistance will be felt worldwide, hitting low- and middle-income countries hardest.

This event will launch the final report of the UK’s Review on AMR, which lays out a 10-point plan for beating drug resistance. To tackle the many and diverse challenges of AMR, the plan calls for a global awareness campaign, reduced antibiotic use, improved surveillance, new rapid diagnostics, and a global coalition. 
Now the question remains: how will the global community deliver on this plan? And how can multilateral and bilateral aid best support low- and middle-income countries—especially their health systems—to take significant steps towards the plan? Join us for this important discussion to find out. 


Subscribe today to receive CGD’s latest newsletters and topic updates.